Elevation Wealth Partners’s Cellebrite CLBT Stock Holding History

Elevation Wealth Partners’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$65.7K	Buy	5,833 +2,816	+93%	+$37.5K	0.02%	303
2026 Q2	$44K	Buy	+3,017	New	+$39.9K	0.01%	336

Other funds holding CLBT

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

TFA

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Elevation Wealth Partners's CLBT Position: Q3 2026 in Review

Elevation Wealth Partners increased its Cellebrite (CLBT) stake by 93% in Q3 2026, buying an estimated $37.5K and bringing the position to 5,833 shares worth $65.7K. The position accounts for 0.02% of the portfolio, ranked #303.

Elevation Wealth Partners first reported a position in CLBT in Q2 2026 and has held it in 2 quarters since. 5 funds tracked by Wall St. Rank hold CLBT as of Q3 2026.

Elevation Wealth Partners held 5,833 shares of Cellebrite worth $65.7K as of Q3 2026.
Elevation Wealth Partners bought 2,816 Cellebrite shares in Q3 2026, an estimated $37.5K.
Cellebrite made up 0.02% of Elevation Wealth Partners's portfolio in Q3 2026, its #303 holding.
Elevation Wealth Partners first reported a position in Cellebrite in Q2 2026 and has held it in 2 quarters since.
5 funds tracked by Wall St. Rank held Cellebrite as of Q3 2026.

Based on Elevation Wealth Partners's 13F filing for Q3 2026, filed 7 Oct 2026.